MEETINGS - Conference on Medical Device Vigilance and Post Market Surveillance (UK) February 2002:
This article was originally published in Clinica
A conference on Medical Device Vigilance and Post Market Surveillance will be held on February 23 2002 at The Hatton, London, UK. The event is designed to be an interactive forum for an overview of medical device regulation. Topics include implementation strategies; issues in site training and certification; current challenges; future trends and an overview of the regulatory environment. The conference also features a visit to a PET imaging centre. Further details from SMi Group on tel: +44 (0)207 252 2222; fax: +44 (0)207 252 2272; email: email@example.com www.smi-online.co.uk
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.